| Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978) |
|---|
| 01/20/2005 | CA2529293A1 Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof |
| 01/20/2005 | CA2529292A1 Oxazolidinone antibiotics and derivatives thereof |
| 01/19/2005 | EP1498411A1 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
| 01/19/2005 | EP1497271A1 Indane acetic acid derivatives and their use as pharmaceutical agents |
| 01/19/2005 | EP1497255A2 Method for preparing combretastatins |
| 01/19/2005 | EP1496838A2 Substituted amides |
| 01/19/2005 | EP0958293B1 Nanomolar, non-peptide inhibitors of cathepsin d |
| 01/19/2005 | CN1568316A Activator for peroxisome proliferator-responsive receptor delta |
| 01/19/2005 | CN1568304A Process for the preparation of enantiomerically-enriched cyclopropylalanine derivatives |
| 01/19/2005 | CN1185234C Herbicidally active 3-hydroxy-4-aryl-5-oxopyrazoline derivatives |
| 01/18/2005 | US6844295 2-Pyridin-2-yl derivatives |
| 01/13/2005 | WO2005002514A2 Compounds having inhibitibe activity of phosphatidylinositol 3-kinase and methods of use thereof |
| 01/13/2005 | WO2004099134A3 Glutaminyl based dp iv-inhibitors |
| 01/13/2005 | US20050009912 2-Amino-bicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives; treatment of neurological or psychiatric disorders, such as anxiety disorder; greatly enhanced oral exposure |
| 01/13/2005 | US20050009892 Phenyloxazole derivatives lower blood triglyceride, glucose, insulin; hyperlipidemia, arteriosclerosis, diabetes mellitus, hypertension, obesity; 2-methyl-2-[6-(5-methyl-2-phenyloxazol-4-yl)-(E)-4-hexenyloxy]propionic acid |
| 01/13/2005 | US20050009816 Potassium channel modulators |
| 01/13/2005 | US20050009785 Heterocyclic compounds |
| 01/13/2005 | DE10328174A1 Verfahren zur Herstellung von Aryloxazolylethylalkohol A process for preparing Aryloxazolylethylalkohol |
| 01/12/2005 | EP1495021A2 Antiinfectve compounds, process for their preparation and pharmaceutical compositions containing them |
| 01/12/2005 | EP1495011A1 A semi-synthetic process for the preparation of n debenzoylpaclitaxel |
| 01/12/2005 | EP1495007A1 Process for preparing heteroaryl and unsaturated heterocycloalkylmagnesium reagents and uses |
| 01/12/2005 | EP1494997A1 Substituted aryl amides |
| 01/12/2005 | EP1171423B1 Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands |
| 01/12/2005 | EP0944604B1 Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 01/12/2005 | CN1562986A Precursor of key intermediate of AG 7088 class compound and its sythetic process |
| 01/12/2005 | CN1562984A Compound of hydrosulfuryl-substitution azacycle |
| 01/12/2005 | CN1184215C Substd. oxazoles and thiazoles derivs. as HPPAR alpha activators |
| 01/12/2005 | CN1184213C Methods for crystalization of N-(1-(s)-ethoxycarbonyl-3-phenylpropyl)-L- alanine N-carboxyanhydride |
| 01/11/2005 | US6841684 Imidiazoles having reduced side effects |
| 01/11/2005 | US6841682 Prevent binding of adrenergenic receptors |
| 01/06/2005 | WO2005000852A2 Product containing at least one phosphatase cdc25 inhibitor combined with at least one other anticancer agent |
| 01/06/2005 | WO2005000824A1 Lazolidine derivatives as herbicidal agents |
| 01/06/2005 | WO2005000406A2 Treatment of amyloid- and epileptogenesis-associated diseases |
| 01/06/2005 | WO2005000309A2 Chemical compounds |
| 01/06/2005 | WO2005000298A2 5-membered heterocycle-based p-38 inhibitors |
| 01/06/2005 | WO2004101573A9 Synthesis of substituted heterocyclic compounds |
| 01/06/2005 | US20050004188 cytotoxic secondary metabolites; selective towards cancer cells magnesium ion binders |
| 01/06/2005 | US20050004174 Antibacterial agents |
| 01/06/2005 | US20050004133 Inhibiting ligand gated ion channel vanilloid receptor (VR1); pain relievers; such as 6-(3,4-dichloro-phenyl)-N-(2-oxo-2,3-dihydro-1H-benzoimidazol-5-yl)-nicotinamide |
| 01/06/2005 | CA2556706A1 Treatment of amyloid- and epileptogenesis-associated diseases |
| 01/06/2005 | CA2530668A1 Product containing at least one phosphatase cdc25 inhibitor combined with at least one other anticancer agent |
| 01/06/2005 | CA2530662A1 Benzothiazole-4,7-diones and benzoxazole-4,7-diones with substituents in position 5 or 6 and method for production thereof |
| 01/06/2005 | CA2528438A1 P-38 inhibitors |
| 01/05/2005 | EP1493733A2 Fungicidal heterocyclic aromatic amides, their compositions and methods of use |
| 01/05/2005 | EP1492797A1 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the production thereof |
| 01/05/2005 | EP1492773A2 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation |
| 01/05/2005 | EP1492768A1 Phenethylacrylamide, methods for the production thereof and agents containing the same |
| 01/05/2005 | EP1492756A1 Novel thyroid receptor ligands |
| 01/05/2005 | EP1492528A1 Antidiabetic agents |
| 01/05/2005 | EP1282414B1 Felbamate derived compounds for treating neuropathic pain |
| 01/05/2005 | CN1561327A Novel aminobenzoephenones |
| 01/05/2005 | CN1561246A Compositions of cyclooxygenase-2 selective inhibitors and radiation for inhibition or prevention of cardiovascular disease |
| 01/05/2005 | CN1561212A Benzimidazolidinone derivatives as muscarinic agents |
| 01/05/2005 | CN1561211A Nociceptin analogs |
| 01/05/2005 | CN1560040A Preparation process of chlorazol thazone |
| 01/05/2005 | CN1560038A Compound of substituted benzo heterocyclic by electrophosphorescence and luminous ligand thereof |
| 01/05/2005 | CN1183113C Tri-aryl acid derivatives as PPAR receptor ligands |
| 01/04/2005 | US6838562 Salt formation of creatine and orotic acid; water solubility, stability, bioavailability |
| 12/30/2004 | US20040266844 Antimicrobial and radioprotective compounds |
| 12/30/2004 | US20040266833 Novel use of certain insulin sensitizers or ppar-gamma agonists |
| 12/30/2004 | US20040266830 Insulin sensitivity enhancer and second antidiabetic of different mechanism; suppressing hyperglycemia |
| 12/30/2004 | US20040266788 treatment of diabetes and/or cancer; useful in the treatment of syndrome X; capable of inhibiting Protein tyrosine phosphatase |
| 12/29/2004 | WO2004113308A1 Method for producing aryl oxazolyl ethyl alcohol |
| 12/29/2004 | WO2004099175A3 Blockers of the quorum sensing system of gram-negative bacteria |
| 12/29/2004 | WO2004075815A3 Diarylcycloalkyl derivatives, method for their production and their use as medicaments |
| 12/29/2004 | EP1491536A1 Compound, photosensitive composition, lithographic printing plate precursor, and method of forming image |
| 12/29/2004 | EP1491525A1 Process for producing beta-aminoketone and catalyst therefor |
| 12/29/2004 | EP1491194A1 Vdac regulator |
| 12/29/2004 | EP1491190A1 Decomposition inhibitor for extracellular matrix of cartilage |
| 12/29/2004 | EP1490339A1 Novel chalcone derivatives and uses thereof |
| 12/29/2004 | EP1490062A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 12/29/2004 | EP1490059A1 Parenteral, intravenous, and oral administration of oxazolidinones for treating diabetic foot infections |
| 12/29/2004 | CN1558905A Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 12/29/2004 | CN1558897A Antidiabetic agents |
| 12/29/2004 | CN1558717A Optically active herbicidal (R)-phenoxypropionic acid-N-methyl-N-2-fluorophenyl amides |
| 12/29/2004 | CN1557809A Process for synthesis of chiral oxazolidine-2-thioketone compounds |
| 12/28/2004 | US6835860 Halogenation with iodine monochloride and iodine monobromide in an aqueous solution, forming a chemical intermediate for the preparation of indinavir, an HIV protease enzyme inhibitor |
| 12/28/2004 | US6835831 Efficient synthesis of ceramide-like compounds by reacting an aldehyde and an amidomethylisonitrile to form a 4-amido-2-oxazoline; suppress biosynthesis of glycosphingolipids; antitumor agents; Tays-Sach, Gaucher's |
| 12/23/2004 | WO2004111020A1 Aniline derivatives |
| 12/23/2004 | WO2004110986A1 Benzamide derivative or salt thereof |
| 12/23/2004 | WO2004110439A1 Polyene oxazoles with antitumour activity and processes for their preparation using a streptomyces strain |
| 12/23/2004 | WO2004074270A3 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same |
| 12/23/2004 | WO2004071447A3 Substituted azole derivatives as therapeutic agents |
| 12/23/2004 | WO2004064771A3 Geminally di-substituted nsaid derivatives as abeta 42 lowering agents |
| 12/23/2004 | US20040260095 human immunodeficiency virus (HIV) protease inhibitors; AIDS; prophylaxis |
| 12/23/2004 | US20040259950 Dicarboxy compounds for use as drugs and receptors for proliferation |
| 12/23/2004 | US20040259877 Inhibitors against the production and release of inflammatory cytokines |
| 12/23/2004 | US20040259875 Incontinence; overactive bladder; neuropathic pain; neuralgia; analgesics; stroke; antiarthritic agents; antiinflammatory agents |
| 12/23/2004 | DE10308355A1 Aryl-cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel Aryl-cycloalkyl substituted alkane acid derivatives, processes for their preparation and their use as medicaments |
| 12/23/2004 | DE10308354A1 Cycloalkylderivate mit biosteren Carbonsäure-Gruppen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Cycloalkyl biosteren with carboxylic acid groups, method for their preparation and their use as medicaments |
| 12/23/2004 | CA2527246A1 Aniline derivatives |
| 12/23/2004 | CA2526387A1 Benzamide derivative or salt thereof |
| 12/23/2004 | CA2526285A1 Inhibitors of p38 and methods of using the same |
| 12/22/2004 | EP1487843A2 Substituted phenylacetic acids |
| 12/22/2004 | EP1487794A1 Monocyclic aroylpyridinones as antiinflammatory agents |
| 12/22/2004 | EP1487785A2 Novel florfenicol-type antibiotics |
| 12/22/2004 | EP1487430A1 Methods for treating diseases related to intraocular pressure |
| 12/22/2004 | EP1373264B1 3-heterocyclylpropanohydroxamic acid as procollagen c-proteinase inhibitors |
| 12/22/2004 | EP0987254B1 Novel cyclic diamine compounds and medicine containing the same |
| 12/22/2004 | CN1181077C Ion liquid |